Literature DB >> 26461072

Opioid Therapy and Sleep Disorders: Risks and Mitigation Strategies.

Martin D Cheatle1, Lynn R Webster2.   

Abstract

OBJECTIVE: Patients with chronic pain frequently experience concomitant sleep disorders. There has been controversy on whether opioids have a beneficial or deleterious effect on sleep quality, duration and efficiency. There is also concern regarding the association between chronic opioid therapy (COT) and sleep disordered breathing (SDB) and the increased risk for unintentional opioid related overdose. This article provides a narrative review of the literature on the effect of opioids on sleep disorders and discusses risk assessment and mitigation strategies.
DESIGN: A narrative review of the current literature on the effect of prescription opioids on sleep quality and efficiency, the relationship between opioids and sleep disorders and potential risk factors in patients with chronic pain.
RESULTS: There is conflicting evidence regarding the benefit of opioids in improving sleep quality, duration and efficiency with several studies and reviews suggesting a beneficial effect of opioids on sleep and other studies demonstrating the opioids can cause sleep disturbance leading to hyperalgesia. There was credible evidence of a strong relationship between opioids and SDB with noted risk factors including use of methadone, high opioid dosing (>200 mg MED) and combining opioids with benzodiazepines.
CONCLUSIONS: Further research is required to elucidate the effect of prescription opioids on sleep quality and pain intensity and the risks associated with opioids and SDB. The risk of SDB should be routinely assessed in patients on COT. Wiley Periodicals, Inc.

Entities:  

Keywords:  Chronic Pain; Methadone; Opioid Therapy; Sleep Disordered Breathing

Mesh:

Substances:

Year:  2015        PMID: 26461072      PMCID: PMC4608386          DOI: 10.1111/pme.12910

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  28 in total

Review 1.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

2.  An analysis of the root causes for opioid-related overdose deaths in the United States.

Authors:  Lynn R Webster; Susan Cochella; Nabarun Dasgupta; Keri L Fakata; Perry G Fine; Scott M Fishman; Todd Grey; Erin M Johnson; Lewis K Lee; Steven D Passik; John Peppin; Christina A Porucznik; Albert Ray; Sidney H Schnoll; Richard L Stieg; Wayne Wakeland
Journal:  Pain Med       Date:  2011-06       Impact factor: 3.750

3.  Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.

Authors:  Jacques R Caldwell; Ronald J Rapoport; Jeffrey C Davis; Howard L Offenberg; Howard W Marker; Sanford H Roth; William Yuan; Lise Eliot; Najib Babul; Pia Mikkelsen Lynch
Journal:  J Pain Symptom Manage       Date:  2002-04       Impact factor: 3.612

4.  Development of a sleep diary for chronic pain patients.

Authors:  J A Haythornthwaite; M T Hegel; R D Kerns
Journal:  J Pain Symptom Manage       Date:  1991-02       Impact factor: 3.612

Review 5.  Sleep disturbances in patients with chronic pain: effectively managing opioid analgesia to improve outcomes.

Authors:  Michael J Brennan; Joseph A Lieberman
Journal:  Curr Med Res Opin       Date:  2009-05       Impact factor: 2.580

6.  Sleep loss and REM sleep loss are hyperalgesic.

Authors:  Timothy Roehrs; Maren Hyde; Brandi Blaisdell; Mark Greenwald; Thomas Roth
Journal:  Sleep       Date:  2006-02       Impact factor: 5.849

7.  Osteoarthritis and sleep: the Johnston County Osteoarthritis Project.

Authors:  Kelli D Allen; Jordan B Renner; Brenda Devellis; Charles G Helmick; Joanne M Jordan
Journal:  J Rheumatol       Date:  2008-05-15       Impact factor: 4.666

Review 8.  The significance of dysfunctions of the sleeping/waking brain to the pathogenesis and treatment of fibromyalgia syndrome.

Authors:  Harvey Moldofsky
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

Review 9.  Opioids compared to placebo or other treatments for chronic low-back pain.

Authors:  Luis Enrique Chaparro; Andrea D Furlan; Amol Deshpande; Angela Mailis-Gagnon; Steven Atlas; Dennis C Turk
Journal:  Cochrane Database Syst Rev       Date:  2013-08-27

10.  Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.

Authors:  Li Hui Chen; Holly Hedegaard; Margaret Warner
Journal:  NCHS Data Brief       Date:  2014-09
View more
  18 in total

1.  Sleep problems in advanced disease .

Authors:  Andrew Davies
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

2.  Sleep science in anesthesiology.

Authors:  Tetsuya Kushikata
Journal:  J Anesth       Date:  2019-04-06       Impact factor: 2.078

Review 3.  Medication Overuse in Chronic Pain.

Authors:  Eric S Hsu
Journal:  Curr Pain Headache Rep       Date:  2017-01

4.  Self-reported Sleep Improvement in Buprenorphine MAT (Medication Assisted Treatment) Population.

Authors:  W H Zheng; R J Wakim; R C Geary; L R Lander; S J Wen; M C Xiao; C R Sullivan
Journal:  Austin J Drug Abuse Addict       Date:  2016-07-25

5.  Sustained Benefits of Exercise-based Motivational Interviewing, but Only among Nonusers of Opioids in Patients with Fibromyalgia.

Authors:  Sunghye Kim; James E Slaven; Dennis C Ang
Journal:  J Rheumatol       Date:  2016-12-01       Impact factor: 4.666

6.  Opioid prescribing and adverse events in opioid-naive patients treated by emergency physicians versus family physicians: a population-based cohort study.

Authors:  Bjug Borgundvaag; Shelley McLeod; Wayne Khuu; Catherine Varner; Mina Tadrous; Tara Gomes
Journal:  CMAJ Open       Date:  2018-03-01

7.  The relationship between past 12-month suicidality and reasons for prescription opioid misuse.

Authors:  Lisham Ashrafioun; Sarah Heavey; Taraneh Canarapen; Todd M Bishop; Wilfred R Pigeon
Journal:  J Affect Disord       Date:  2019-02-06       Impact factor: 4.839

8.  Interacting Influences of Sleep, Pain, and Analgesic Medications on Sleep Studies in Rodents.

Authors:  Linda A Toth
Journal:  Comp Med       Date:  2019-06-18       Impact factor: 0.982

9.  Pain intensity as a moderator of the association between opioid use and insomnia symptoms among adults with chronic pain.

Authors:  Mary Beth Miller; Wai Sze Chan; Ashley F Curtis; Jeff Boissoneault; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  Sleep Med       Date:  2018-09-05       Impact factor: 3.492

10.  Prevalence and drug use correlates of extra-medical use of prescription medications for sleep among adults in the United States: Results of the 2015-2018 National Survey on Drug Use and Health.

Authors:  Catalina Lopez-Quintero; Trey Warren; Alyssa Falise; Vinita Sharma; Cristina Bares; Assaf Oshri
Journal:  Pharmacol Biochem Behav       Date:  2021-03-06       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.